BDBM473013 (R)-3-chloro-4-(3,3,3-trifluoropropyl)- 6,6a,7,8,9,10-hexahydro-5H-pyrazino[1,2- a][1,8]naphthyridine::US10836764, Compound 167

SMILES FC(F)(F)CCc1c(Cl)cnc2N3CCNC[C@H]3CCc12

InChI Key InChIKey=VNFDDQKZHIOOLW-SECBINFHSA-N

Data  3 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 473013   

Target5-hydroxytryptamine receptor 2C(Human)
Arena Pharmaceuticals

US Patent
LigandPNGBDBM473013((R)-3-chloro-4-(3,3,3-trifluoropropyl)- 6,6a,7,8,9...)
Affinity DataKi:  3.67nMAssay Description:Radioligand binding assays were performed using the commercially available 5-HT2 receptor agonist [125I]DOI as the radioligand and nonspecific bindin...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Arena Pharmaceuticals

US Patent
LigandPNGBDBM473013((R)-3-chloro-4-(3,3,3-trifluoropropyl)- 6,6a,7,8,9...)
Affinity DataKi:  34.1nMAssay Description:Radioligand binding assays were performed using the commercially available 5-HT2 receptor agonist [125I]DOI as the radioligand and nonspecific bindin...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

Target5-hydroxytryptamine receptor 2B(Human)
Arena Pharmaceuticals

US Patent
LigandPNGBDBM473013((R)-3-chloro-4-(3,3,3-trifluoropropyl)- 6,6a,7,8,9...)
Affinity DataKi:  39.7nMAssay Description:Radioligand binding assays were performed using the commercially available 5-HT2 receptor agonist [125I]DOI as the radioligand and nonspecific bindin...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent